ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Alf107
|
905 |
269K |
5 |
20/07/24 |
20/07/24 |
ASX - By Stock
|
905
|
269K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Alf107
|
905 |
269K |
0 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
905
|
269K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Alf107
|
905 |
269K |
6 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
905
|
269K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Alf107
|
905 |
269K |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
905
|
269K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Alf107
|
905 |
269K |
1 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
905
|
269K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
Alf107
|
905 |
269K |
6 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
905
|
269K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?
|
|
Alf107
|
391 |
81K |
7 |
11/07/24 |
11/07/24 |
ASX - By Stock
|
391
|
81K
|
7
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
3 |
25/06/24 |
25/06/24 |
ASX - By Stock
|
1.2K
|
435K
|
3
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
22K |
7.7M |
6 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
22K
|
7.7M
|
6
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
1 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: FDA RPD Designation Granted for RC220 Bisantrene
|
|
Alf107
|
80 |
25K |
18 |
18/06/24 |
18/06/24 |
ASX - By Stock
|
80
|
25K
|
18
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
2 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
1.2K
|
435K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
0 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.2K
|
435K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Alf107
|
1.0K |
305K |
19 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
1.0K
|
305K
|
19
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
1 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1.2K
|
435K
|
1
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
0 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
1.2K
|
435K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
[WEBINAR REPLAY] What it takes to get a new drug to market in Australia
|
|
Alf107
|
37 |
9.2K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
37
|
9.2K
|
1
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
417 |
124K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
417
|
124K
|
0
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
417 |
124K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
417
|
124K
|
2
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
417 |
124K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
417
|
124K
|
1
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
417 |
124K |
5 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
417
|
124K
|
5
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
417 |
124K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
417
|
124K
|
2
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
417 |
124K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
417
|
124K
|
0
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
417 |
124K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
417
|
124K
|
2
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
417 |
124K |
5 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
417
|
124K
|
5
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
417 |
124K |
8 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
417
|
124K
|
8
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
0 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
1.2K
|
435K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Alf107
|
234 |
65K |
4 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
234
|
65K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Alf107
|
234 |
65K |
12 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
234
|
65K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Alf107
|
234 |
65K |
13 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
234
|
65K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Alf107
|
1.0K |
305K |
10 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
1.0K
|
305K
|
10
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
3 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
1.2K
|
435K
|
3
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
2 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
1.2K
|
435K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Corporate Spotlight Advertisement.on HC
|
|
Alf107
|
37 |
11K |
13 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
37
|
11K
|
13
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
22K |
7.7M |
12 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
22K
|
7.7M
|
12
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Completion of Ground Geophysics Enhances Targets
|
|
Alf107
|
358 |
102K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
358
|
102K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 cGMP Manufacturing Complete
|
|
Alf107
|
76 |
27K |
23 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
76
|
27K
|
23
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
22K |
7.7M |
26 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
22K
|
7.7M
|
26
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
3 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.2K
|
435K
|
3
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
2 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
1.2K
|
435K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
4 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
1.2K
|
435K
|
4
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.2K |
435K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
1.2K
|
435K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Alf107
|
113 |
27K |
2 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
113
|
27K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
22K |
7.7M |
20 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
22K
|
7.7M
|
20
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
11K |
4.0M |
14 |
29/11/23 |
29/11/23 |
General
|
11K
|
4.0M
|
14
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
11K |
4.0M |
42 |
29/11/23 |
29/11/23 |
General
|
11K
|
4.0M
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
Alf107
|
508 |
129K |
6 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
129K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
Alf107
|
226 |
57K |
7 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
57K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
Alf107
|
226 |
57K |
19 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
57K
|
19
|
|